NO20056070L - Anti artrittkombinasjoner - Google Patents

Anti artrittkombinasjoner

Info

Publication number
NO20056070L
NO20056070L NO20056070A NO20056070A NO20056070L NO 20056070 L NO20056070 L NO 20056070L NO 20056070 A NO20056070 A NO 20056070A NO 20056070 A NO20056070 A NO 20056070A NO 20056070 L NO20056070 L NO 20056070L
Authority
NO
Norway
Prior art keywords
combinations
arthritis
anti arthritis
inhibition
therapy
Prior art date
Application number
NO20056070A
Other languages
English (en)
Inventor
Heather Anne Harris
Damien P Quinn
Regina H Kurrasch
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20056070L publication Critical patent/NO20056070L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Det beskrives kombinasjoner av en ER-ß selektiv ligand med et anti-artrittmiddel. Kombinasjonene finner anvendelse ved terapi eller inhibering av artritt.
NO20056070A 2003-05-21 2005-12-20 Anti artrittkombinasjoner NO20056070L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47238203P 2003-05-21 2003-05-21
PCT/US2004/016030 WO2004103365A1 (en) 2003-05-21 2004-05-20 Antiarthritic combinations

Publications (1)

Publication Number Publication Date
NO20056070L true NO20056070L (no) 2006-02-14

Family

ID=33476949

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056070A NO20056070L (no) 2003-05-21 2005-12-20 Anti artrittkombinasjoner

Country Status (17)

Country Link
US (1) US20040248865A1 (no)
EP (1) EP1631283A1 (no)
JP (1) JP2007500223A (no)
KR (1) KR20060013666A (no)
CN (1) CN1791404A (no)
AR (1) AR044428A1 (no)
AU (1) AU2004240668A1 (no)
BR (1) BRPI0411145A (no)
CA (1) CA2524116A1 (no)
CL (1) CL2004001186A1 (no)
EC (1) ECSP056177A (no)
MX (1) MXPA05012562A (no)
NO (1) NO20056070L (no)
RU (1) RU2005140041A (no)
TW (1) TW200500065A (no)
WO (1) WO2004103365A1 (no)
ZA (1) ZA200509376B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060121111A1 (en) * 2004-12-02 2006-06-08 Wyeth Formulations of substituted benzoxazoles
US20060210644A1 (en) * 2004-12-16 2006-09-21 Bruce Levin Materials, methods, and devices for treatment of arthropathies and spondylopathies
WO2006104172A1 (ja) * 2005-03-29 2006-10-05 Kowa Co., Ltd. 関節リウマチの予防及び／又は治療薬
CA2641116A1 (en) * 2006-02-14 2007-08-23 Wyeth Aqueous pharmaceutical formulations of er.beta. selective ligands
BRPI0910735A2 (pt) * 2008-04-22 2019-09-24 Toyama Chemical Co Ltd uso de um derivado de benzofenona e de um ou mais agentes imunossupressores em combinação, composição farmacéutica para o tratamento de doenças autoimunes, e, kit
CN102427822A (zh) * 2009-05-18 2012-04-25 香港大学 治疗炎症性关节炎的组合物和方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
CN1261098C (zh) * 1998-08-28 2006-06-28 西奥斯股份有限公司 p38－α激酶的抑制剂
US6080580A (en) * 1998-10-05 2000-06-27 Isis Pharmaceuticals Inc. Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
US6225311B1 (en) * 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
US6541477B2 (en) * 1999-08-27 2003-04-01 Scios, Inc. Inhibitors of p38-a kinase
US20070004713A1 (en) * 2000-12-07 2007-01-04 Bernard Barlaam Therapeutic benimidazole compounds
US6589980B2 (en) * 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
TWI306450B (en) * 2001-12-13 2009-02-21 Wyeth Corp Substituted phenyl naphthalenes as estrogenic agents

Also Published As

Publication number Publication date
JP2007500223A (ja) 2007-01-11
ZA200509376B (en) 2007-04-25
MXPA05012562A (es) 2006-04-18
KR20060013666A (ko) 2006-02-13
AR044428A1 (es) 2005-09-14
AU2004240668A1 (en) 2004-12-02
BRPI0411145A (pt) 2006-07-11
EP1631283A1 (en) 2006-03-08
CA2524116A1 (en) 2004-12-02
US20040248865A1 (en) 2004-12-09
CL2004001186A1 (es) 2005-04-15
CN1791404A (zh) 2006-06-21
ECSP056177A (es) 2006-04-19
WO2004103365A1 (en) 2004-12-02
RU2005140041A (ru) 2006-05-10
TW200500065A (en) 2005-01-01

Similar Documents

Publication Publication Date Title
NO20071926L (no) Anvendelse av en mTOR-inhibitor i behandling av uterint leioyom.
WO2006015263A3 (en) Lonidamine analogs
CY2014028I1 (el) Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης
PL1713503T3 (pl) Hamowanie czynnika B, alternatywny szlak dopełniacza i związane z tym sposoby
NO20064130L (no) Antineoplastiske kombinasjoner av CCI-779 og rituximab
NO20056070L (no) Anti artrittkombinasjoner
DE60332475D1 (de) Zusammensetzungen verwendbar für die hemmung von rock und anderen kinasen
NO20023050L (no) Fremgangsmåte samt anlegg for utf degree relse av fremgangsmåten
CL2007002261A1 (es) Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
BRPI0506629A (pt) inibição do fator b, a via alternativa do sistema complemento e métodos relacionados
NO20033651L (no) Cancerbehandling
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
DE602004024037D1 (de) Substituierte heterozyklen
ATE412220T1 (de) Fft-architektur und -verfahren
BRPI0507463A (pt) uso de glufosfamide e gemcitabine , produto, e, combinação de glufosfamide e gemcitabine
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
DE50307886D1 (de) Leitungsführungseinheit zur aktiven führung von leitungen, kabeln oder dergleichen
MXPA04006572A (es) Terapia de combinacion antivirica.
HK1071784A1 (en) Impeller and sewage treatment pump including the same
IL173188A0 (en) Use of alcohol-oxyalkyates in the form of adjuvants for benzamidoxime gungicidal derivatives, appropriate agents and kits
NL1025873A1 (nl) Doseringsvormen en wijzen van behandeling met vegfr-remmers.
HRP20090513T1 (en) S-mirtazapine for the treatment of hot flush
DK1644076T3 (da) Topisk sammensætning til behandling af akne og rosacea med galvanisk genereret elektricitet
UY28344A1 (es) Nuevos compuestos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application